Stock Rich List
#535 on the corporate holders of 809 holders

Casdin Partners FO1-MSV, LP

10% owner at GeneDx Holdings; Director at Standard BioTools.

$152M
in disclosed stock, −$8.1M (−5.06%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
535th of 809
Companies held
2
Largest holding
WGS, 98.4% of total
Latest SEC filing
May 28, 2024
Listed but not counted
$60.6M

What the $152M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
GeneDx Holdings WGS
Class A Common Stock
Directly2,923,509$49.24$144M94.8%Form 4, May 28, 2024
GeneDx Holdings WGS
Class A Common Stock
Indirectly (see filing footnote)
Reported jointly by 3 insiders; split evenly
111,048$49.24$5.5M3.6%Form 4, May 23, 2024
Standard BioTools LAB
Common Stock
Indirectly (see filing footnote)
Reported jointly by 2 insiders; split evenly
3,774,000$0.61$2.3M1.5%Form 4, May 23, 2024
Standard BioTools LAB
Common Stock
Directly103,556$0.61$64K0.0%Form 4, May 23, 2024

Share counts are the amounts Casdin Partners FO1-MSV, LP reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Reported but not counted

These shares appear on Casdin Partners FO1-MSV, LP's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.

CompanyHow heldSharesPriceValueShare of totalReported
Standard BioTools LAB
Common Stock
Through Casdin Partners Master Fund, L.P.
Held by a company or fund the insider manages
46,075,821$0.61$28.3M—Form 4, May 23, 2024
GeneDx Holdings WGS
Class A Common Stock
Through CMLS Holdings LLC
Held by a company or fund the insider manages
432,902$49.24$21.3M—Form 4, May 23, 2024
Standard BioTools LAB
Common Stock
Through Casdin Private Growth Equity Fund II, L.P.
Held by a company or fund the insider manages
13,939,637$0.61$8.6M—Form 4, May 23, 2024
Standard BioTools LAB
Common Stock
Through Casdin Partners FO1-MSV, LP
Held by a company or fund the insider manages
2,744,219$0.61$1.7M—Form 4, May 23, 2024
Standard BioTools LAB
Common Stock
Through CMLS Holdings II LLC
Held by a company or fund the insider manages
1,200,000$0.61$737K—Form 4, May 23, 2024

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
532Mpm Asset Management LLC
10% owner, Aktis Oncology
$153M+$2.4M (+1.58%)
533RC IV Cayman ICW Equity LLC
Insider, Driven Brands Holdings
$152M−$2.1M (−1.37%)
534Honeywell International INC
10% owner, Quantinuum
$152M−$567K (−0.37%)
535Casdin Partners FO1-MSV, LP
10% owner, GeneDx Holdings
$152M−$8.1M (−5.06%)
536Third Rock Ventures VI, L.P.
10% owner, Rapport Therapeutics
$152M+$1.2M (+0.81%)
537General Catalyst Group VIII Supplemental, L.P.
10% owner, Samsara
$151M−$5.8M (−3.71%)
538Siddhi Sponsor LLC
10% owner, Siddhi Acquisition
$150M+$141K (+0.09%)

Other GeneDx Holdings insiders

All WGS insiders

Questions

How much stock does Casdin Partners FO1-MSV, LP own?

Casdin Partners FO1-MSV, LP holds $151,802,406 in listed stock based on SEC filings and current prices, mostly GeneDx Holdings (WGS). That ranks 535th on the Stock Rich List.

Is this Casdin Partners FO1-MSV, LP's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with SEC filer 1534264.